2001
Hormone replacement therapy and reduced cognitive decline in older women
Carlson M, Zandi P, Plassman B, Tschanz J, Welsh-Bohmer K, Steffens D, Bastian L, Mehta K, Breitner J. Hormone replacement therapy and reduced cognitive decline in older women. Neurology 2001, 57: 2210-2216. PMID: 11756599, DOI: 10.1212/wnl.57.12.2210.Peer-Reviewed Original ResearchConceptsHormone replacement therapyModified Mini-Mental State ExaminationMMSE scoresReplacement therapyHealth QuestionnaireOlder womenPostmenopausal hormone replacement therapySelf-perceived general healthHealthy lifestyleMini-Mental State ExaminationWomen's Health QuestionnairePresence of apoERecency of exposureGlobal cognitive changeHRT exposureHRT usersHRT useIncident dementiaCalcium supplementsAPOE epsilon4General healthAPOE genotypeChronic diseasesBaseline interviewState Examination
1999
HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER
Nanda K, Bastian L, Hasselblad V, Simel D. HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER. Obstetrics And Gynecology 1999, 93: 880-888. DOI: 10.1097/00006250-199905001-00041.Peer-Reviewed Original ResearchHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen usersHormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstetrics And Gynecology 1999, 93: 880-8. PMID: 10912438, DOI: 10.1016/s0029-7844(98)00424-4.Peer-Reviewed Original ResearchConceptsHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen users
1998
Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Primary Care Update For OB/GYNS 1998, 5: 165. PMID: 10838309, DOI: 10.1016/s1068-607x(98)00064-x.Peer-Reviewed Original ResearchHormone replacement therapySummary relative riskRectal cancer incidenceHRT usersColon cancerReplacement therapyCancer incidenceRelative riskUse of HRTRisk estimatesPostmenopausal HRT usersRetrievable risk estimatesColorectal cancer incidenceAdjusted risk estimatesColon cancer mortalityRisk of deathMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language studiesTime of assessmentEstrogen usersHRT use